Oncogene

Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.

Oncogene

Valdmanis PN, Roy-Chaudhuri B, Kim HK, Sayles LC, Zheng Y, Chuang CH, Caswell DR, Chu K, Zhang Y, Winslow MM, Sweet-Cordero EA, Kay MA

Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.

Oncogene

Valdmanis PN, Roy-Chaudhuri B, Kim HK, Sayles LC, Zheng Y, Chuang CH, Caswell DR, Chu K, Zhang Y, Winslow MM, Sweet-Cordero EA, Kay MA

Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.

Oncogene

Chen X, Wu Q, Tan L, Porter D, Jager MJ, Emery C, Bastian BC

Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.

Oncogene

Chen X, Wu Q, Tan L, Porter D, Jager MJ, Emery C, Bastian BC

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer.

Oncogene

Postel-Vinay S, Bajrami I, Friboulet L, Elliott R, Fontebasso Y, Dorvault N, Olaussen KA, André F, Soria JC, Lord CJ, Ashworth A

Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.

Oncogene

Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Geiselhart L, Kaffenberger T, Rachakonda PS, Bauer A, Giese N, Hong C, Xie H, Costello JF, Hoheisel J, Kumar R, Rehli M, Schirmacher P, Werner J, Plass C, Popanda O, Schmezer P

Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.

Oncogene

Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Geiselhart L, Kaffenberger T, Rachakonda PS, Bauer A, Giese N, Hong C, Xie H, Costello JF, Hoheisel J, Kumar R, Rehli M, Schirmacher P, Werner J, Plass C, Popanda O, Schmezer P

Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.

Oncogene

Panupinthu N, Yu S, Zhang D, Zhang F, Gagea M, Lu Y, Grandis JR, Dunn SE, Lee HY, Mills GB

Pages